Iohexol Injectable Solution Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 240 mg/mL, 300 mg/mL, 350 mg/mL, 140 mg/mL
Reference Brands: Omnipaque(US & EU)
Category: Contrast Agent
Iohexol is a non-ionic, low-osmolar iodinated contrast medium for CT scans, angiography, urography and myelography. It comes in strengths of 140 to 350 mg iodine per ml, in bottles and bags. The original brand is Omnipaque (GE HealthCare). PharmaTradz sources it for importers, hospitals and tenders, and shares GMP certificates and CoA before you commit.
Manufacture or export Iohexol Injectable Solution? List it or send an offer →
Product Description:
Iohexol injectable solution, marketed as Omnipaque, is approved in the US by the FDA and in the EU via EMA for use as a contrast agent in diagnostic imaging. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety, efficacy, and manufacturing regulations. Proper adherence supports swift approval, safe administration, and broad global availability, enabling precise imaging for effective diagnosis and treatment planning worldwide.
Iohexol Injectable Solution — third party manufacturing & bulk supply
Iohexol Injectable Solution is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Iohexol Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Iohexol Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Iohexol Injectable Solution →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Iohexol Injectable is a contrast agent used in diagnostic imaging procedures, including X-rays, CT scans, and angiography. It enhances the visibility of blood vessels, organs, and tissues to help healthcare professionals accurately diagnose medical conditions.
It contains iohexol, a non-ionic, water-soluble iodinated contrast medium that increases the contrast of structures in radiographic imaging. The solution is sterile and formulated for safe intravenous, intra-arterial, or other parenteral administration.
Common trade names include Omnipaque and Accupaque, depending on the manufacturer and region.
It is manufactured by several pharmaceutical companies, including GE Healthcare (Omnipaque) and multiple generic manufacturers in different countries.
The generic name is iohexol.
Brand names include Omnipaque, Accupaque, and various generics depending on the region.
It is manufactured globally, including the USA, Europe, India, and other regions, depending on the brand and pharmaceutical company.
240–350 mg iodine/ml for CT and angiography, lower strengths for urography and some oral uses, and specific strengths for myelography.
Kidney function checks in at-risk patients, thyroid effects, and screening for previous contrast reactions.
In glass bottles and plastic bottles from 50 to 500 ml, stored at room temperature and protected from light.
Related Products
Iopamidol Injectable Solution
Strength:
37%, 61%, 76%, and 78%
Form: Injectable Solution
Reference Brands: Isovue(US), Iopamiro(EU)
View DetailsIopromide Injectable Solution
Strength:
300 mg/mL, 370 mg/mL
Form: Injectable Solution
Reference Brands: Ultravist(US & EU)
View DetailsIoversol Injectable Solution
Strength:
320 mg/mL, 350 mg/mL, 370 mg/mL
Form: Injectable Solution
Reference Brands: Optiray(US & EU)
View DetailsIomeprol Injectable Solution
Strength:
350 mg/mL and 400 mg/mL
Form: Injectable Solution
Reference Brands: Iomeron(US & EU)
View DetailsGadofosveset Injectable Solution
Strength:
0.03 mmol/kg
Form: Injectable Solution
Reference Brands: Ablivar(US & EU)
View DetailsGadoxetate Injectable Solution
Strength:
0.25 mmol/mL
Form: Injectable Solution
Reference Brands: Eovist(US)
View DetailsBarium Sulfate Suspension
Strength:
30% w/v , 40% w/v
Form: Powder for oral suspension
Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)
View DetailsSulfur Hexafluoride Microbubbles Injection
Strength:
60.7mg
Form: injection
Reference Brands: SonoVue(EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit